Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong
· Delayed Price · Currency is HKD 41.74
+0.42 (1.02%)
At close: Apr 29, 2026
Sunshine Lake Pharma Revenue
In the year 2025, Sunshine Lake Pharma had annual revenue of 4.82B CNY with 29.31% growth. Sunshine Lake Pharma had revenue of 2.88B in the half year ending December 31, 2025, a decrease of -6.75%.
Revenue
4.82B CNY
Revenue Growth
+29.31%
P/S Ratio
4.44
Revenue / Employee
737.04K CNY
Employees
6,533
Market Cap
23.80B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.82B | 1.09B | 29.31% |
| Dec 31, 2024 | 3.72B | -2.57B | -40.84% |
| Dec 31, 2023 | 6.29B | 2.55B | 68.08% |
| Dec 31, 2022 | 3.74B | 2.83B | 309.83% |
| Dec 31, 2021 | 913.79M | -1.43B | -61.08% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grand Pharmaceutical Group | 12.28B |
| The United Laboratories International Holdings | 14.70B |
| Simcere Pharmaceutical Group | 8.60B |
| China Medical System Holdings | 9.14B |
| Fujian Haixi Pharmaceuticals | 648.05M |
| China Resources Pharmaceutical Group | 299.99B |
| Consun Pharmaceutical Group | 3.80B |
| CanSino Biologics | 1.19B |